Skip to main content
HighTide Therapeutics, Inc. logo

HighTide Therapeutics, Inc. — Investor Relations & Filings

Ticker · 2511 HKEX Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2025-07-07 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2511

About HighTide Therapeutics, Inc.

http://www.hightidetx.com

HighTide Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative, multifunctional, multi-targeted therapies. The company is dedicated to addressing unmet needs within the spectrum of inter-related chronic metabolic diseases, specifically emphasizing Cardiovascular-Kidney-Metabolic (CKM) conditions. HighTide's therapeutic strategy targets diseases driven by underlying mechanisms such as insulin resistance and chronic inflammation. The product pipeline includes five candidates covering nine indications in metabolic and digestive diseases. The lead candidate, HTD1801, is currently being advanced in chronic metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis), Type 2 Diabetes Mellitus (T2DM), Obesity, Primary Sclerosing Cholangitis (PSC), and Chronic Kidney Disease (CKD), utilizing its dual mechanism of action.

Recent filings

Filing Released Lang Actions
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is a Hong Kong stock exchange announcement by HighTide Therapeutics, Inc. titled “Completion of Placing of New Shares Under General Mandate.” It details the successful placement of 56,555,000 new shares, the placing price, net proceeds, and the effect on shareholding structure. This is specifically an announcement of a share issue under the company’s general mandate and not a full annual or interim report, dividend notice, or regulatory notice. Accordingly, it falls under the category “Share Issue/Capital Change” (SHA).
2025-07-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Share Issue/Capital Change Classification · 1% confidence The document is a monthly return filed under HKEX Listing Rules (Chapter 19B) detailing movements in authorised share capital, issued shares, treasury shares, share options, warrants, convertibles and related confirmations. It is not an annual or interim report, earnings release, or proxy material, but a regulatory filing specifically documenting capital changes and share issuances. This aligns with the "Share Issue/Capital Change" category (SHA).
2025-07-02 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27, 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an announcement of the poll voting results for ordinary resolutions at the company’s Annual General Meeting held on June 27, 2025, detailing vote counts for each resolution. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2025-06-27 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is substantially an announcement of a placing of 60,000,000 new shares by the Company under its general mandate, detailing the terms of the share issue, placing agents, pricing, conditions precedent, use of proceeds and effects on shareholding. It is not a full financial report or earnings release but a capital raising transaction via new share issuance. This matches the definition for a Share Issue/Capital Change announcement (Code: SHA).
2025-06-26 English
2025 SHARE INCENTIVE PLAN
Regulatory Filings Classification · 1% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2025-06-12 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 27, 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Form of Proxy” for the company’s upcoming Annual General Meeting, providing shareholders with voting instructions and proxy appointment details. It is clearly a proxy solicitation document sent to shareholders to request their votes at the AGM, rather than the actual AGM presentation materials or voting results. This aligns with the definition of “Proxy Solicitation & Information Statement (PSI).”
2025-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.